173 related articles for article (PubMed ID: 25622689)
1. What's new in atopic eczema? An analysis of systematic reviews published in 2012 and 2013. Part 1. Epidemiology, mechanisms of disease and methodological issues.
Madhok V; Futamura M; Thomas KS; Barbarot S
Clin Exp Dermatol; 2015 Apr; 40(3):238-42. PubMed ID: 25622689
[TBL] [Abstract][Full Text] [Related]
2. What's new in atopic eczema? An analysis of systematic reviews published in 2014. Part 1. Epidemiology, risk factors and outcomes.
Hatfield SJ; Rogers NK; Lloyd-Lavery A; Grindlay D; Barnett R; Thomas KS
Clin Exp Dermatol; 2016 Dec; 41(8):843-846. PubMed ID: 27805275
[TBL] [Abstract][Full Text] [Related]
3. What's new in atopic eczema? An analysis of systematic reviews published in 2016. Part 3: nomenclature and outcome assessment.
Lloyd-Lavery A; Solman L; Grindlay DJC; Rogers NK; Thomas KS; Harman KE
Clin Exp Dermatol; 2019 Jun; 44(4):376-380. PubMed ID: 30706507
[TBL] [Abstract][Full Text] [Related]
4. What's new in atopic eczema? An analysis of systematic reviews published in 2015. Part 1: epidemiology and methodology.
Davies E; Rogers NK; Lloyd-Lavery A; Grindlay DJC; Thomas KS
Clin Exp Dermatol; 2018 Jun; 43(4):375-379. PubMed ID: 29314180
[TBL] [Abstract][Full Text] [Related]
5. What's new in atopic eczema? An analysis of systematic reviews published in 2007 and 2008. Part 1. Definitions, causes and consequences of eczema.
Williams HC; Grindlay DJ
Clin Exp Dermatol; 2010 Jan; 35(1):12-5. PubMed ID: 19874343
[TBL] [Abstract][Full Text] [Related]
6. What's new in atopic eczema? An analysis of systematic reviews published in 2016. Part 2: Epidemiology, aetiology and risk factors.
Lloyd-Lavery A; Solman L; Grindlay DJC; Rogers NK; Thomas KS; Harman KE
Clin Exp Dermatol; 2019 Jun; 44(4):370-375. PubMed ID: 30706503
[TBL] [Abstract][Full Text] [Related]
7. What's new in atopic eczema? An analysis of systematic reviews published in 2017. Part 2: epidemiology, aetiology and risk factors.
Hale G; Davies E; Grindlay DJC; Rogers NK; Harman KE
Clin Exp Dermatol; 2019 Dec; 44(8):868-873. PubMed ID: 31502320
[TBL] [Abstract][Full Text] [Related]
8. What's new in atopic eczema? An analysis of systematic reviews published in 2012 and 2013. Part 2. Treatment and prevention.
Madhok V; Futamura M; Thomas KS; Barbarot S
Clin Exp Dermatol; 2015 Jun; 40(4):349-54; quiz 354-5. PubMed ID: 25622761
[TBL] [Abstract][Full Text] [Related]
9. What's new in atopic eczema? An analysis of systematic reviews published in 2014. Part 2. Treatment and prevention.
Lloyd-Lavery A; Rogers NK; Hatfield SJ; Grindlay D; Barnett R; Thomas KS
Clin Exp Dermatol; 2017 Jan; 42(1):3-7. PubMed ID: 27868221
[TBL] [Abstract][Full Text] [Related]
10. The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials.
Schmitt J; Spuls PI; Thomas KS; Simpson E; Furue M; Deckert S; Dohil M; Apfelbacher C; Singh JA; Chalmers J; Williams HC;
J Allergy Clin Immunol; 2014 Oct; 134(4):800-7. PubMed ID: 25282560
[TBL] [Abstract][Full Text] [Related]
11. Early exposure to antibiotics and infections and the incidence of atopic eczema: a population-based cohort study.
Schmitt J; Schmitt NM; Kirch W; Meurer M
Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):292-300. PubMed ID: 19725897
[TBL] [Abstract][Full Text] [Related]
12. What's new in atopic eczema? An analysis of systematic reviews published in 2015. Part 2: prevention and treatment.
Lloyd-Lavery A; Rogers NK; Davies E; Grindlay DJC; Thomas KS
Clin Exp Dermatol; 2018 Aug; 43(6):653-658. PubMed ID: 29806218
[TBL] [Abstract][Full Text] [Related]
13. What's new in atopic eczema? An analysis of systematic reviews published in 2009-2010.
Shams K; Grindlay DJ; Williams HC
Clin Exp Dermatol; 2011 Aug; 36(6):573-7; quiz 577-8. PubMed ID: 21718344
[TBL] [Abstract][Full Text] [Related]
14. What's new in atopic eczema? An analysis of systematic reviews published in 2019. Part 1: Risk factors and prevention.
Earp E; Tsianou Z; Grindlay DJC; Rogers NK; Olabi B
Clin Exp Dermatol; 2021 Oct; 46(7):1205-1210. PubMed ID: 34080217
[TBL] [Abstract][Full Text] [Related]
15. Analysis of correlations between patient-oriented SCORAD (PO-SCORAD) and other assessment scores of atopic dermatitis severity and quality of life.
Coutanceau C; Stalder JF
Dermatology; 2014; 229(3):248-55. PubMed ID: 25196258
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review.
Gerbens LA; Prinsen CA; Chalmers JR; Drucker AM; von Kobyletzki LB; Limpens J; Nankervis H; Svensson Å; Terwee CB; Zhang J; Apfelbacher CJ; Spuls PI;
Allergy; 2017 Jan; 72(1):146-163. PubMed ID: 27322918
[TBL] [Abstract][Full Text] [Related]
17. What's in a name? Atopic dermatitis or atopic eczema, but not eczema alone.
Silverberg JI; Thyssen JP; Paller AS; Drucker AM; Wollenberg A; Lee KH; Kabashima K; Todd G; Schmid-Grendelmeier P; Bieber T
Allergy; 2017 Dec; 72(12):2026-2030. PubMed ID: 28605026
[TBL] [Abstract][Full Text] [Related]
18. What are the best outcome measurements for atopic eczema? A systematic review.
Schmitt J; Langan S; Williams HC;
J Allergy Clin Immunol; 2007 Dec; 120(6):1389-98. PubMed ID: 17910890
[TBL] [Abstract][Full Text] [Related]
19. What's new in atopic eczema? An analysis of systematic reviews published in 2010-11.
Torley D; Futamura M; Williams HC; Thomas KS
Clin Exp Dermatol; 2013 Jul; 38(5):449-56. PubMed ID: 23750610
[TBL] [Abstract][Full Text] [Related]
20. Chinese herbal medicine for atopic eczema: an overview of clinical evidence.
Gu SX; Zhang AL; Coyle ME; Chen D; Xue CC
J Dermatolog Treat; 2017 May; 28(3):246-250. PubMed ID: 27538116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
